Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.90
-0.22 (-3.59%)
At close: Sep 14, 2026, 4:00 PM EDT
6.07
+0.17 (2.86%)
After-hours: Sep 14, 2026, 6:29 PM EDT
Orchestra BioMed Holdings Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Orchestra BioMed Holdings stock has a consensus rating of "Strong Buy" and an average price target of $12. The average 1-year stock price forecast is 103.39% higher than the current stock price, while the lowest is $9.00 (+52.54%) and the highest is $20 (+238.98%).
Price Target: $12 (+103.39%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Orchestra BioMed Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Upgrades $10 | Buy | Upgrades | $10 | +69.49% | Sep 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +69.49% | Aug 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $9 → $10 | Buy | Reiterates | $9 → $10 | +69.49% | Aug 11, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $12 → $10 | Buy | Reiterates | $12 → $10 | +69.49% | May 19, 2026 |
| Barclays | Barclays | Buy Reiterates $12 → $13 | Buy | Reiterates | $12 → $13 | +120.34% | May 13, 2026 |
Financial Forecast
Revenue This Year
448.71K
from 33.48M
Decreased by -98.66%
Revenue Next Year
578.57K
from 448.71K
Increased by 28.94%
EPS This Year
-1.52
from -1.11
EPS Next Year
-1.52
from -1.52
EPS and Forward PE are based on non-GAAP adjusted numbers.